Education
About Us
Working with TipRanks
Follow Us
Noxopharm Ltd. (AU:NOX)
ASX:NOX
Sof-Skn 0.25%, Sof-Skn 0.5%, Sof-Skn 1%, Sof-Skn 2%
Cutaneous Lupus Erythematosus
Early Phase I
Recruiting
Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants
Jun 16, 2025
―
Doxorubicin, Nox66
Metastatic Soft-Tissue Sarcoma
Phase I
Terminated
A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma
Oct 20, 2021
―
Nox66, Irradiation Therapy
Cancer
Phase I
Completed
Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer
Sep 27, 2017
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Noxopharm Ltd. (NOX) have in its pipeline
NOX is currently developing the following drugs: Sof-Skn 0.25%, Sof-Skn 0.5%, Sof-Skn 1%, Sof-Skn 2%, Doxorubicin, Nox66, Nox66, Irradiation Therapy. These drug candidates are in various stages of clinical development as the company works toward FDA approval.